Tel：
(86)(21)60969600
Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
Recently, the 10th Asian Cardiac Arrhythmia Summit (ACAS 2025) and the 16th Chinese Cardiac Arrhythmia Summit (CCAS 2025) were successfully held in Shenzhen. Shanghai MicroPort EP MedTech Co., Ltd. (referred to as "MicroPort EP") actively participated in the exhibition with a range of core products, showcasing a comprehensive new landscape for the interventional diagnosis and treatment of rapid cardiac arrhythmias.
During the exhibition, MicroPort EP displayed a variety of innovative products in the field of electrophysiological interventional diagnosis and ablation therapy, including the Columbus™ 3D EP Navigation System (referred to as "Columbus™ System") with its AutoPilot™ automatic mapping function, the FireMagic™ TrueForce™ Ablation Catheter (referred to as "TrueForce™ Ablation Catheter"), the EasyStars™ 3D High-density Mapping Catheter, the IceMagic™ Cryoablation Catheter, and the PathBuilder™ Transseptal Guiding Introducer, among other full-series products. Additionally, the recently NMPA-approved Magbot™ Ablation Catheter made its debut at the exhibition, attracting significant attention and inquiries from numerous experts.
During the conference, MicroPort EP hosted an international symposium titled "Frontier Exploration of Clinical Applications of the Columbus™ System: International Case Sharing." Experts from overseas shared their latest research findings and clinical experiences in various fields, fully affirming the advancements in domestic medical devices and their advantages in practical applications.
This academic event was co-chaired by Professor Yao Yan from Fuwai Hospital of the Chinese Academy of Medical Sciences and Professor Jose Luis Merino from La Paz University Hospital in Spain. The honorary chairs included Professor Mervat Abouelmaaty from Ain Shams University Hospital in Egypt, Professor Néstor Hugo López Cabanillas, President of the Latin American Heart Rhythm Society and Director of the Cardiovascular Institute of Buenos Aires in Argentina, and Professor Juan Carlos Zerpa Acosta, Vice President of the Latin American Heart Rhythm Society and Director of the Cardiac Center at the Brazilian Charitable Association. Professor Zahra Emkanjoo from Rajaie Cardiovascular Medical and Research Center in Iran served as the moderator. Distinguished discussants included Professor Zeng Rui and Professor Cui Kaijun from West China Hospital of Sichuan University, Professor Zheng Wenqing from Weihai Central Hospital, Professor Li Jinyi from Guilin Medical University Affiliated Hospital, and Professor Wen Liang from Xijing Hospital, contributing to a spectacular international and domestic academic exchange.
Dr. Hikmet Yorgun from Hacettepe University Hospital in Turkey delivered a detailed presentation on the "Clinical Applications of the Columbus™ System at Hacettepe University Hospital," focusing on the newly launched AutoPilot™ automatic mapping function for complex arrhythmias. He highlighted the product combination and workflow of the EasyLoop™ 3D Circular Mapping Catheter and the TrueForce™ Ablation Catheter, sharing mapping experiences in complex cases. Dr. Yorgun emphasized the high-precision mapping capability of the Columbus™ System, praising its ability to accurately locate gaps in complex atrial arrhythmias, providing critical support for clinical treatment.
Professor Néstor Hugo López Cabanillas, President of the Latin American Heart Rhythm Society and Director of the Cardiovascular Institute of Buenos Aires, shared a clinical case and experience on "Cardiac Neuromodulation for Cardioinhibitory Syncope Using High-Density Mapping Technology." As an authority in the field, Professor Cabanillas provided an in-depth yet accessible introduction to the advanced progress and applications of cardiac electrophysiology technology in Latin America, sparking lively discussions among the attending experts.
Dr. Akmal Yakubov from the Tashkent Cardiology Center in Uzbekistan presented "The Application of the TrueForce™ Ablation Catheter in Pulmonary Vein Isolation: Personal Perspectives and Clinical Experience," delving into the clinical challenges of radiofrequency ablation and pulmonary vein isolation. He particularly emphasized the significant advantages of the Columbus™ System in visualization and positioning accuracy (with errors controlled within 1 millimeter). Dr. Yakubov noted that the pressure-sensing technology of the TrueForce™ Ablation Catheter effectively optimized catheter contact force, significantly improving ablation outcomes. Additionally, the introduction of the EI index addressed the issue of insufficient assessment of ablation lesion depth by operators, further ensuring patient safety and surgical success rates.
Professor Juan Carlos Zerpa Acosta, Vice President of the Latin American Heart Rhythm Society and Director of the Cardiac Center at the Brazilian Charitable Association, explored the latest advancements in atrial fibrillation treatment in his presentation "Atrial Fibrillation Treatment: Cardiac Neuromodulation and Pulmonary Vein Isolation." As a key topic in electrophysiology, Professor Acosta highlighted the latest research findings on the combined approach of ganglionated plexus ablation and pulmonary vein isolation. Studies have shown that this combined procedure significantly enhances surgical success rates, offering new clinical insights and treatment directions for atrial fibrillation management.
Dr. Farid Aliyev from Baku General Hospital in Azerbaijan shared "Clinical Applications of the Columbus™ System at Baku General Hospital," introducing Azerbaijan's first zero-fluoroscopy electrophysiological procedure using the Columbus™ System. Dr. Aliyev detailed how the Columbus™ System was utilized to successfully complete the procedure on a pregnant patient and shared strategies for performing zero-fluoroscopy surgeries. This case fully demonstrated the advantages of the Columbus™ System in magnetic and electric navigation precision and anatomical structure mapping, significantly reducing intraoperative X-ray use and achieving safe and efficient surgical outcomes. Dr. Aliyev emphasized that this case not only showcased the stability and precision of the Columbus™ System but also proved its advanced capabilities and broad application value in diverse clinical scenarioses.
This conference brought together electrophysiology experts from around the world, who shared cutting-edge technologies and valuable experiences in arrhythmia treatment from various perspectives. The showcased technologies demonstrated significant breakthroughs in precise positioning, real-time monitoring, and safe and efficient ablation. Experts universally praised these innovations for their contributions to improving surgical success rates, optimizing treatment processes, and ensuring patient safety.
In the future, MicroPort EP will continue to advance on the path of academic sharing and scientific innovation, providing patients and physicians with more comprehensive products and professional services, and delivering globally competitive integrated solutions for electrophysiological interventional diagnosis and treatment.
